Exousia Bio reported total assets of $22.05M and total liabilities of $0.26M for the quarter ended Feb 2026. This balance sheet covers 16 quarters of results from May 2022 through Feb 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | May2022 | Aug2022 | Nov2022 | Feb2023 | May2023 | Aug2023 | Nov2023 | Feb2024 | May2024 | Aug2024 | Nov2024 | Feb2025 | May2025 | Aug2025 | Nov2025 | Feb2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Current Assets | ||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 0.01M | 0.00M | 0.00M | 0.01M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | |||||
| Cash & Current Investments | 0.01M | 0.00M | 0.00M | 0.01M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | |||||
| Receivables - NetNet Receivables | 0.00M | 0.01M | 0.01M | 0.02M | 0.02M | |||||||||||
| Receivables - OtherOther Receivables | 436.00 | 867.00 | 0.00M | |||||||||||||
| Receivables | 0.00M | 0.01M | 0.01M | 0.02M | 0.02M | |||||||||||
| Current Assets | 0.01M | 0.00M | 0.01M | 0.00M | 0.00M | 0.01M | 0.01M | 0.02M | 0.02M | |||||||
| Non-Current Assets | ||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.02M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.00M | 0.00M | 0.00M | 670.00 | 670.00 | |||||
| Intangibles | 0.03M | 0.02M | 0.02M | 0.02M | 0.01M | 0.01M | 0.01M | 0.01M | 0.00M | |||||||
| Goodwill & Intangibles | 0.03M | 0.02M | 0.02M | 0.02M | 0.01M | 0.01M | 0.01M | 0.01M | 0.00M | |||||||
| Long-Term Deferred Tax | 0.01M | 0.01M | 0.01M | 0.02M | 0.02M | 0.02M | 0.02M | 717.00 | 717.00 | 0.02M | ||||||
| Other Non-Current Assets | 22.05M | 22.05M | ||||||||||||||
| Non-Current Assets | 0.04M | 0.03M | 0.03M | 0.03M | 0.02M | 0.02M | 0.01M | 0.01M | 0.01M | 22.05M | 22.05M | |||||
| Assets | 0.05M | 0.04M | 0.04M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.02M | 22.05M | 22.05M | |||||
| Liabilities | ||||||||||||||||
| Current Liabilities | ||||||||||||||||
| Accounts Payables | 0.21M | 0.21M | ||||||||||||||
| Payables | 0.21M | 0.21M | ||||||||||||||
| Accumulated Expenses | 333.00 | 0.00M | 0.01M | 0.00M | 0.01M | 0.01M | 0.01M | 0.01M | ||||||||
| Other Accumulated Expenses | 0.00M | 0.00M | ||||||||||||||
| Total Current Liabilities | 0.00M | 0.00M | 0.00M | 0.01M | 0.01M | 0.01M | 0.02M | 0.04M | 0.26M | 0.26M | ||||||
| Non-Current Liabilities | ||||||||||||||||
| Non-Current Debt | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | ||||||||
| Total Non-Current Liabilities | 0.05M | 0.06M | 0.06M | 0.06M | 0.07M | 0.07M | 0.07M | 0.07M | ||||||||
| Total Liabilities | 0.05M | 0.06M | 0.07M | 0.07M | 0.07M | 0.08M | 0.08M | 0.09M | 0.04M | 0.26M | 0.26M | |||||
| Shareholder's Equity | ||||||||||||||||
| Total Debt | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | ||||||||
| Common Equity | -437.00 | -0.01M | -0.02M | -0.03M | -0.03M | -0.04M | -0.04M | -0.05M | -0.05M | -0.06M | 0.02M | 0.02M | -0.04M | 21.79M | 21.79M | |
| Liabilities and Shareholders Equity | 0.05M | 0.04M | 0.04M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.02M | 22.05M | 22.05M | |||||
| Retained Earnings | -937.00 | -0.03M | -0.06M | -0.07M | -0.07M | -0.08M | -0.08M | -0.09M | 0.03M | -0.03M | -0.03M | -0.06M | 22.07M | 22.07M |